Regeneron (REGN) announces EMA Issues Advice on its Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients

Go back to Regeneron (REGN) announces EMA Issues Advice on its Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Regeneron (NASDAQ: REGN) Delayed: 612.50 --0 (-0%)
Previous Close $612.50    52 Week High $592.36 
Open $612.50    52 Week Low $325.35 
Day High $612.50    P/E 160.76 
Day Low $612.50    EPS $3.81 
Volume 1,312